"Investigation of the Relationship Between New Coronary Virus Disease (COVID-19) and Anxiety and Depressive Symptoms in Pregnant Women"
''(COVID-19) and Anxiety and Depressive Symptoms in Pregnant Women"
1 other identifier
observational
100
1 country
1
Brief Summary
In our study; Anxiety and depression levels, socio-demographic characteristics of the pregnant women who were admitted to our hospital between 25.04.2020-25.07.2020 and treated with the diagnosis of covid 19, and the change in anxiety and depression levelsWİTH Beck Depression and Anxiety Score after the disease regressed are planned. (Beck depression scale contains 10 questions and a total of 1 to 100 points is obtained. High score indicates that depression and anxiety are high.) 0-16 points = mild depressive symptoms 17-29 points = moderate depressive symptoms 30-63 points = severe depressive symptoms
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 25, 2020
CompletedFirst Submitted
Initial submission to the registry
May 11, 2020
CompletedFirst Posted
Study publicly available on registry
May 12, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 25, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 26, 2020
CompletedSeptember 2, 2020
May 1, 2020
4 months
May 11, 2020
August 31, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluation of depression and anxiety score changes of covid-19 positive pregnants
Evaluation of depression and anxiety score changes of covid-19 positive pregnants Pregnant women are questioned how this period was affected, as the pandemic period loaded with extra stress and caused depression and anxiety.
4 months
Interventions
It is planned to receive pregnant women who are admitted to the clinic or outpatient clinic and who are offered inpatient follow-up and treatment with the diagnosis of COVID-19. Pregnant women who do not have covid-19 disease as a control group and who do not have a comorbid disease at similar gestational week will be included in the study. As a control group, covid-19 pcr negative patients will be admitted to our clinic in the same period.
Eligibility Criteria
Pregnant women with a positive covid -19 pcr test between the ages of 18 and 45 will be included in the study and beck and anxiety tests will be performed 3 months after birth.
You may qualify if:
- covid -19 pcr positive pregnant women
- no psychiatric diagnosis no use of psychiatric medicine
You may not qualify if:
- Non-pregnant patients, A psychiatric diagnosis use of psychiatric medicine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kanuni Sultan Suleyman Training and Research Hospitallead
- Ayşegül Bestelcollaborator
- İbrahim Polatcollaborator
- Merve Aldıkaçtıoğlu Talmaçcollaborator
Study Sites (1)
Pinar Yalcin Bahat
Istanbul, İ̇stanbul, 34000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 11, 2020
First Posted
May 12, 2020
Study Start
April 25, 2020
Primary Completion
August 25, 2020
Study Completion
August 26, 2020
Last Updated
September 2, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will share